Trial intelligence / Profile preview

Ivabradine for prevention of postoperative atrial fibrillation after CABG

PACTR202103543569729Completed

Sponsor
Alexandria University
Start
Jun 2020
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Trial of ivabradine and bisoprolol in Atrial fibrillation (AFib) (2 arms), sponsored by Alexandria University. Primary endpoint: Atrial fibrillation. Started Jun 2020; status: completed.

02

Drugs

ivabradinebisoprolol
03

Conditions

Atrial fibrillation (AFib)

Beyond the preview

Go deeper on PACTR202103543569729.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR202103543569729.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call